HomeTYP • ASX
add
Tryptamine Therapeutics Ltd
Nakaraang pagsara
$0.043
Sakop ng araw
$0.044 - $0.048
Sakop ng taon
$0.017 - $0.057
Market cap
60.78M AUD
Average na Volume
5.98M
P/E ratio
-
Dividend yield
-
Primary exchange
ASX
Sa balita
Mga Financial
Income Statement
Kita
Net na kita
| (CAD) | Peb 2024info | Y/Y na pagbabago |
|---|---|---|
Kita | — | — |
Gastos sa pagpapatakbo | 745.86K | -41.07% |
Net na kita | -988.18K | 23.20% |
Net profit margin | — | — |
Kita sa bawat share | -0.01 | 0.00% |
EBITDA | — | — |
Aktuwal na % ng binabayarang buwis | — | — |
Balance Sheet
Kabuuang asset
Kabuuang sagutin
| (CAD) | Peb 2024info | Y/Y na pagbabago |
|---|---|---|
Cash at mga panandaliang investment | 420.81K | 859.80% |
Kabuuang asset | 703.97K | 40.49% |
Kabuuang sagutin | 6.56M | 230.26% |
Kabuuang equity | -5.86M | — |
Natitirang share | 96.42M | — |
Presyo para makapag-book | -0.72 | — |
Return on assets | -122.01% | — |
Return on capital | 859.21% | — |
Cash Flow
Net change in cash
| (CAD) | Peb 2024info | Y/Y na pagbabago |
|---|---|---|
Net na kita | -988.18K | 23.20% |
Cash mula sa mga operasyon | -1.66M | -110.13% |
Cash mula sa pag-invest | — | — |
Cash mula sa financing | 22.21K | — |
Net change in cash | -1.64M | -107.44% |
Malayang cash flow | -1.34M | -354.19% |
Tungkol
Itinatag
2019
Website
